Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other β-lactams

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 2, 1997, Pages 141-148

  Spangler, S K ^a   Jacobs, M R ^b   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFDINIR; CEFDITOREN; CEFIXIME; CEFPODOXIME; CEFUROXIME; FROPENEM; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TIME;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0031057095     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.2.141     Document Type: Article

References (30)

1. Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77-83.
2. Jacobs, M. R. & Appelbaum, P. C. (1995). Antibiotic-resistant pneumococci. Reviews in Medical Microbiology 6, 77-93.
3. McDougal, L. K., Facklam, R., Reeves, M., Hunter, S., Swenson, J. M., Hill, B. C. et al. (1992). Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrobial Agents and Chemotherapy 36, 2176-84.
4. Munoz, R., Musser, J. M., Grain, M., Briles, D. E., Marton, A., Parkinson, A. J. et al. (1992). Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clinical Infectious Diseases 15, 112-8.
5. Spika, J. S., Facklam, R. R., Plikaytis, B. D., Oxtoby, M. J. and the Pneumococcal Surveillance Working Group (1991). Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. Journal of Infectious Diseases 163, 1273-8.
6. Breiman, R. F., Butler, J. C., Tenover, F. C., Elliott, J. A. & Facklam, R. R. (1994). Emergence of drug-resistant pneumococcal infections in the United States. Journal of the American Medical Association 271, 1831-5.
7. Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A. et al. (1995). The prevalence of drugresistant Streptococcus pneumoniae in Atlanta. New England Journal of Medicine 333, 481-6.
8. Jacobs, M. R. (1992). Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clinical Infectious Diseases 15, 119-27.
9. Friedland, I. R. & Istre, G. R. (1992). Management of penicillin-resistant pneumococcal infections. Pediatric Infectious Disease Journal 11, 433-5.
10. Friedland, I. R. & McCracken, G. H. (1994). Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New England Journal of Medicine 331, 377-82.
11. París, M. M., Ramilo, O. & McCracken, G. H. (1995). Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 39, 2171-5.
12. Block, S., Hedrick, J., Wright, P., Finger, R., Leggiadro, R., Appleton, M. et al. (1994). Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee, 1993. Morbidity and Mortality Weekly Report 43, 23-5.
13. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1996). Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrobial Agents and Chemotherapy 40, 481-4.
14. Fremaux, A., Sissia, G., Rosembaum, M. & Geslin, P. (1992). In vitro activity of cefpirome (HR 810), a new parenteral cephalosporin, against penicillin susceptible and resistant pneumococci. In Program and Abstracts of the Thirty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, 1992. Abstract 1020, p. 280. American Society for Microbiology, Washington, DC.
15. Liñares, J., Alonso, T., Pérez, J. L., Ayats, J., Domǐnguez, M. A., Pallarés, R. et al. (1992). Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 30, 279-88.
16. Spangler, S. K., Jacobs, M. R., Pankuch, G. A. & Appelbaum, P. C. (1993). Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. Journal of Antimicrobial Chemotherapy 31, 273-80.
17. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1994). In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrobial Agents and Chemotherapy 38, 2902-4.
18. Nelson, C. T., Mason, E. O. & Kaplan, S. L. (1994). Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatric Infectious Disease Journal 13, 585-9.
19. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 883-8.
20. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third edition: Approved Standard M7-A3. NCCLS, Villanova, PA.
21. National Committee for Clinical Laboratory Standards. (1995). Performance Standards for Antimicrobial Susceptibility Testing: Sixth Informational Supplement M100-S6. NCCLS, Villanova, PA.
22. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1994). Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrobial Agents and Chemotherapy 38, 2065-72.
23. Shimada, K., Shinkai, S., Komiya, I. & Matsumoto, T. (1989). Phase-l clinical studies on a novel orally active cephem antibiotic, ME 1207. In Program and Abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, TX, 1989. Abstract 366, p. 162. American Society for Microbiology, Washington, DC.
24. Goto, S., Miyazaki, S., Ohno, A. & Nasu, T. (1991). Antibacterial activity of SY 5555, a novel oral penem. In Program and Abstracts of the Thirty-First Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 1991. Abstract 821, p. 236. American Society for Microbiology, Washington, DC.
25. Richer, M., Allard, S., Manseau, L., Vallée, F., Pak, R. & LeBel, M. (1995). Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses. Antimicrobial Agents and Chemotherapy 39, 1082-6.
26. Tamura, A., Okamoto, R., Yoshida, T., Yamamoto, H., Kondo, S., Inoue, M. et al. (1988). In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 32, 1421-6.
27. Miyazaki, S., Miyazaki, Y., Tsuji, A., Nishida, M. & Goto, S. (1991). In vitro antibacterial activity of ME1207, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 35, 1691-4.
28. Fremaux, A., Sissia, G., Brumpt, I. & Geslin, P. (1993). Cefditoren (ME-1206), a new cephalosporin: in vitro activity against penicillin susceptible and resistant pneumococci. In Program and Abstracts of the Eighteenth International Congress of Chemotherapy, Stockholm, Sweden. Abstract 998, p. 289.
29. Canton, R., Liñares, J. Martinez-Beltran, J., Tubau, F., Almaraz, F., Alcaide, F. et al. (1994). Bactericidal activity of cefditoren (ME-1206) on Streptococcus pneumoniae and Streptococcus of the viridans group. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract E11, p. 28. American Society for Microbiology, Washington, DC.
30. Negri, M. C., Morosini, M. I., Loza, E. & Baquero, F. (1994). In vitro selective concentrations of cefditoren for penicillin resistant Streptococcus pneumoniae populations. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract E15, p. 28. American Society for Microbiology, Washington, DC.